Scientific Program - Headache
|
Please see below the CONy Scientific Program. Please click on the appropriate section (ordered by ABC) to view the relevant program. Please note that the program and timing is subject to change. To view the program timetable, please click here
|
| Alzheimer's disease & other Dementias | Epilepsy | Headache | History of Neurology in Poland |
| Multiple Sclerosis | Neuroimmunology | Neuropathy |
| Rehabilitation | Stroke | Wilson's disease |
| Headache Section Heads: Oved Daniel, Israel, Alan Rapoport, USA & Maria Magdalena Wysocka-Bakowska, Poland |
|
|||
| 08:45-10:55 |
HEADACHE THERAPY
|
||
| Chairs: Elliott Gross, USA & Kristina Mitosek-Szewczyk, Poland | |||
| 08:45-09:40 | Medication overuse headache (MOH) can be treated with preventive medications without detoxification. | ||
| Capsule: | MOH is usually treated with detoxification from the offending agent first. There is evidence that preventive medications work regardless of detoxification. | ||
| 08:45-08:55 |
Host: Alan Rapoport, USA
|
||
| 08:55-09:10 |
Yes: Jack Schim, USA
|
||
| 09:10-09:25 | No: Robert Shapiro, USA | ||
| 09:25-09:40 | Discussion and Rebuttals | ||
| 09:40-10:35 | The criteria for the diagnosis of trigeminal neuralgia should be changed to allow
sensory loss in the trigeminal distribution. |
||
| Capsule: | The diagnosis of TN is based primarily upon paroxysms of pain in the distribution of the trigeminal nerve, but sensory loss may not be an acceptable finding. Is this concept true? | ||
| 09:40-09:50 |
Host: Lars Edvinsson, Sweden
|
||
| 09:50-10:05 |
Yes: Joanna Zakrzewska, UK
|
||
| 10:05-10:20 | No: Stine Maabjerg, Denmark | ||
| 10:20-10:35 | Discussion and Rebuttals | ||
| 10:35-10:55 |
Lecture: Noninvasive vagus nerve stimulation in primary headaches: Oved Daniel, Israel
|
||
| 10:55-11:10 | Coffee break | ||
| 11:10-13:20 | NON-PHAMACOLOGICAL TREATMENT FOR HEADACHE | ||
| Chairs: George Chakhava, Georgia & Angel Guerrero, Spain | |||
| 11:10-12:05 |
Nutraceuticals are safe and effective as migraine treatments.
|
||
| Capsule: | People who suffer from headache often prefer nutraceutical treatment over traditional pharmacological approaches, due to fear of possible side effects, drug dependence or addiction. Widespread skepticism persists among doctors about the effectiveness of these treatments. | ||
| 11:10-11:20 |
Host: Dimos Mitsikostas, Greece
|
||
| 11:20-11:35 | Pro: Jose Miguel Lainez, Spain | ||
| 11:35-11:50 | Con: Maria-Magdalena Wysocka-Bąkowska, Poland | ||
| 11:50-12:05 | Discussion and Rebuttals | ||
| 12:05-13:00 | Behavioral therapy is more effective, better tolerated and safer than preventive medications for migraine | ||
| Capsule: | Medication and psychological intervention are often used in primary headache disorders Are both necessary? | ||
| 12:05-12:15 | Host: Robert Shapiro, USA | ||
| 12:15-12:30 | Pro: Steve Baskin, USA | ||
| 12:30-12:45 | Con: Hans Hamburger, The Netherlands | ||
| 12:45-13:00 | Discussion and Rebuttals | ||
| 13:00-13:20 |
Lecture: Pipeline in Headache Treatment: Alan Rapoport, USA
|
||
| 13:20-14:20 | Sponsored Symposium (Not for CME) – HALL A | ||
| 14:20-15:05 | Lunch Break & Meet the Expert sessions | ||
| 15:05-16:55 | HEADACHE THERAPY, OLD AND NEW | ||
| Chairs: Parisa Gazerani, Denmark & Ruta Mameniskie, Lithuania | |||
| 15:05-16:00 |
Medical cannabis is effective in chronic headache.
|
||
| Capsule: | The use of medical cannabis in patients with chronic headache varies widely, with contradicting data regarding its efficacy in chronic headache subtypes. | ||
| 15:05-15:15 | Host: Messoud Ashina, Denmark | ||
| 15:15-15:30 | Yes: Hans Hamburger, The Netherlands | ||
| 15:30-15:45 | No: Dimos Mitsikostas, Greece | ||
| 15:45-16:00 | Discussion and Rebuttals | ||
| 16:00-16:55 | Monoclonal antibodies to CGRP will not become first line treatment for the prevention of migraine. | ||
| Capsule: | CGRP plays a crucial role in migraine pathophysiology. Monoclonal antibodies against CGRP or its receptor are promising new therapies for the treatment of migraine | ||
| 16:00-16:10 | Host: Hartmut Goebel, Germany | ||
| 16:10-16:25 | Pro: Christian Lampl, Austria | ||
| 16:25-16:40 | Con: Lars Edvinsson, Sweden | ||
| 16:40-16:55 | Discussion and Rebuttals | ||
| 16:55-17:10 | Coffee Break | ||
| 17:10-19:00 |
MIGRAINE, CAUSES AND MANIFESTATIONS
|
||
| Chair: Gabriela Mihailescu, Romania | |||
| 17:10-18:05 | Head injury can precipitate the onset of migraine. | ||
| Capsule: | Post-traumatic headache may be nonspecific in character. May patients have a symptom pattern indistinguishable from migraine with or without aura? | ||
| 17:15-17:25 | Host: Min Kyung Chu, South Korea | ||
| 17:25-17:35 | Pro: Oved Daniel, Israel | ||
| 17:30-17:50 | Con: Messoud Ashina, Denmark | ||
| 17:50-18:05 | Discussion and Rebuttals | ||
| 18:05-19:00 | Episodic vertigo can be a manifestation of migraine, at times, unaccompanied by headache. | ||
| Capsule: | Vestibular migraine is a term used to describe episodic vertigo in migraine patients, but is it a distinct diagnosis, or simply a sensory manifestation of migraine? | ||
| 18:05-18:15 |
Host: Maria-Magdalena Wysocka-Bąkowska, Poland
|
||
| 18:15-18:30 | Pro: Christian Lampl, Austria | ||
| 18:30-18:45 | Con: Jose Miguel Lainez, Spain | ||
| 18:45-19:00 | Discussion and Rebuttals | ||
